• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SP2509,一种 LSD1 的选择性抑制剂,通过下调β-catenin 信号通路抑制视网膜母细胞瘤的生长。

SP2509, a Selective Inhibitor of LSD1, Suppresses Retinoblastoma Growth by Downregulating β-catenin Signaling.

机构信息

Jiangxi Provincial Key Laboratory of Tumor Metastasis and Precision Therapy, Center Laboratory, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China.

Department of Ophthalmology, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China.

出版信息

Invest Ophthalmol Vis Sci. 2022 Mar 2;63(3):20. doi: 10.1167/iovs.63.3.20.

DOI:10.1167/iovs.63.3.20
PMID:35297943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8944386/
Abstract

PURPOSE

To study the role of lysine-specific demethylase 1 (LSD1) in retinoblastoma (RB) growth and to determine whether the LSD1 inhibitor SP2509 can inhibit RB progression.

METHODS

We detected the levels of LSD1 in 12 RB tissue samples, two RB cell lines (Y79 and Weri-RB1), and a retinal pigment epithelium cell line (ARPE-19). Overexpression or knockdown of LSD1 was performed to examine the role of LSD1 in RB cancer cell survival. In vitro and in vivo experiments were conducted to detect the antitumor effect of SP2509, and the antitumor mechanism of SP2509 was examined by RNA sequencing and Western blot.

RESULTS

LSD1 is overexpressed in RB tissues and cells and increases RB cancer cell viability and colony formation ability. The LSD1 inhibitor SP2509 inhibits RB cell proliferation in vitro and in vivo. Treatment with SP2509 increases the levels of dimethylated histone 3 lysine 4 (H3K4me2) and inhibits the expression of β-catenin signaling pathway-related proteins in RB cells.

CONCLUSIONS

We demonstrated that LSD1 is overexpressed in RB cells and promotes RB cell survival. The LSD1 inhibitor SP2509 exerted strong growth inhibition in vitro and in vivo, which was at least partially mediated by suppression of the β-catenin pathway.

摘要

目的

研究赖氨酸特异性脱甲基酶 1(LSD1)在视网膜母细胞瘤(RB)生长中的作用,并确定 LSD1 抑制剂 SP2509 是否能抑制 RB 进展。

方法

我们检测了 12 个 RB 组织样本、两个 RB 细胞系(Y79 和 Weri-RB1)和一个视网膜色素上皮细胞系(ARPE-19)中 LSD1 的水平。通过过表达或敲低 LSD1 来研究 LSD1 在 RB 癌细胞存活中的作用。进行体外和体内实验来检测 SP2509 的抗肿瘤作用,并通过 RNA 测序和 Western blot 来研究 SP2509 的抗肿瘤机制。

结果

LSD1 在 RB 组织和细胞中过表达,增加了 RB 癌细胞的活力和集落形成能力。LSD1 抑制剂 SP2509 抑制 RB 细胞在体外和体内的增殖。SP2509 处理增加了组蛋白 3 赖氨酸 4 二甲基化(H3K4me2)的水平,并抑制了 RB 细胞中β-连环蛋白信号通路相关蛋白的表达。

结论

我们证明 LSD1 在 RB 细胞中过表达,并促进 RB 细胞存活。LSD1 抑制剂 SP2509 在体外和体内均表现出强烈的生长抑制作用,至少部分是通过抑制β-连环蛋白通路介导的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d2/8944386/3f9fbbb48211/iovs-63-3-20-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d2/8944386/cf0ba3eae362/iovs-63-3-20-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d2/8944386/d81150e004b5/iovs-63-3-20-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d2/8944386/05219a1b06f5/iovs-63-3-20-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d2/8944386/0285bf2b0193/iovs-63-3-20-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d2/8944386/12eb38df8dba/iovs-63-3-20-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d2/8944386/3f9fbbb48211/iovs-63-3-20-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d2/8944386/cf0ba3eae362/iovs-63-3-20-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d2/8944386/d81150e004b5/iovs-63-3-20-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d2/8944386/05219a1b06f5/iovs-63-3-20-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d2/8944386/0285bf2b0193/iovs-63-3-20-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d2/8944386/12eb38df8dba/iovs-63-3-20-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d2/8944386/3f9fbbb48211/iovs-63-3-20-f006.jpg

相似文献

1
SP2509, a Selective Inhibitor of LSD1, Suppresses Retinoblastoma Growth by Downregulating β-catenin Signaling.SP2509,一种 LSD1 的选择性抑制剂,通过下调β-catenin 信号通路抑制视网膜母细胞瘤的生长。
Invest Ophthalmol Vis Sci. 2022 Mar 2;63(3):20. doi: 10.1167/iovs.63.3.20.
2
SP2509, an inhibitor of LSD1, exerts potential antitumor effects by targeting the JAK/STAT3 signaling.SP2509,一种 LSD1 的抑制剂,通过靶向 JAK/STAT3 信号通路发挥潜在的抗肿瘤作用。
Acta Biochim Biophys Sin (Shanghai). 2021 Jul 28;53(8):1098-1105. doi: 10.1093/abbs/gmab083.
3
microRNA-362-3p targets USP22 to retard retinoblastoma growth via reducing deubiquitination of LSD1.miRNA-362-3p 通过降低 LSD1 的去泛素化来靶向 USP22 从而抑制视网膜母细胞瘤的生长。
Cell Cycle. 2021 Feb;20(3):298-307. doi: 10.1080/15384101.2021.1874685. Epub 2021 Jan 21.
4
Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells.LSD1(KDM1A)拮抗剂与泛组蛋白去乙酰化酶抑制剂联合使用对人急性髓系白血病细胞具有高效作用。
Leukemia. 2014 Nov;28(11):2155-64. doi: 10.1038/leu.2014.119. Epub 2014 Apr 4.
5
Dysregulation of miR-204-3p Driven by the Viability and Motility of Retinoblastoma via Wnt/β-catenin Pathway In Vitro and In Vivo.miR-204-3p 的失调受体外和体内视网膜母细胞瘤活力和迁移能力的调控,通过 Wnt/β-catenin 通路。
Pathol Oncol Res. 2020 Jul;26(3):1549-1558. doi: 10.1007/s12253-019-00722-0. Epub 2019 Sep 3.
6
CircTET1 Inhibits Retinoblastoma Progression via Targeting miR-492 and miR-494-3p through Wnt/β-catenin Signaling Pathway.环状 RNA TET1 通过靶向 Wnt/β-catenin 信号通路抑制视网膜母细胞瘤的进展。
Curr Eye Res. 2021 Jul;46(7):978-987. doi: 10.1080/02713683.2020.1843685. Epub 2021 May 7.
7
LSD1 (KDM1A)-independent effects of the LSD1 inhibitor SP2509 in cancer cells.赖氨酰特异性去甲基化酶1(KDM1A)抑制剂SP2509在癌细胞中的非赖氨酰特异性去甲基化酶1依赖性作用
Br J Haematol. 2018 Nov;183(3):494-497. doi: 10.1111/bjh.14983. Epub 2017 Dec 3.
8
CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression.赖氨酸特异性去甲基化酶 1 抑制剂 CBB1003 通过下调富含亮氨酸重复的 G 蛋白偶联受体 5 的表达抑制结肠直肠癌细胞生长。
J Cancer Res Clin Oncol. 2015 Jan;141(1):11-21. doi: 10.1007/s00432-014-1782-4. Epub 2014 Jul 25.
9
MicroRNA-98 targets HMGA2 to inhibit the development of retinoblastoma through mediating Wnt/β-catenin pathway.MicroRNA-98 通过调控 Wnt/β-catenin 通路靶向 HMGA2 抑制视网膜母细胞瘤的发生发展。
Cancer Biomark. 2019;25(1):79-88. doi: 10.3233/CBM-182315.
10
Lysine-specific demethylase 1 (LSD1/KDM1A) contributes to colorectal tumorigenesis via activation of the Wnt/β-catenin pathway by down-regulating Dickkopf-1 (DKK1) [corrected].赖氨酸特异性去甲基化酶 1(LSD1/KDM1A)通过下调 Dickkopf-1(DKK1)[已更正]来激活 Wnt/β-连环蛋白通路,从而促进结直肠肿瘤的发生。
PLoS One. 2013 Jul 26;8(7):e70077. doi: 10.1371/journal.pone.0070077. Print 2013.

引用本文的文献

1
Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression.解析视网膜母细胞瘤中的代谢异质性揭示了单羧酸转运蛋白1在肿瘤进展中的作用。
Biomark Res. 2024 May 11;12(1):48. doi: 10.1186/s40364-024-00596-8.
2
Inhibition of LSD1 via SP2509 attenuated the progression of rheumatoid arthritis.通过 SP2509 抑制 LSD1 可减轻类风湿关节炎的进展。
Immunol Res. 2024 Aug;72(4):797-810. doi: 10.1007/s12026-024-09486-5. Epub 2024 May 9.
3
LncRNA LOXL1-AS1 promotes proliferation and invasion and inhibits apoptosis in retinoblastoma by regulating the MAPK signaling pathway.

本文引用的文献

1
Orbital Retinoblastoma Treated with Intra-arterial Chemotherapy.经动脉内化疗治疗的眼眶视网膜母细胞瘤
Ophthalmology. 2021 Oct;128(10):1437. doi: 10.1016/j.ophtha.2021.03.018.
2
SP2509, an inhibitor of LSD1, exerts potential antitumor effects by targeting the JAK/STAT3 signaling.SP2509,一种 LSD1 的抑制剂,通过靶向 JAK/STAT3 信号通路发挥潜在的抗肿瘤作用。
Acta Biochim Biophys Sin (Shanghai). 2021 Jul 28;53(8):1098-1105. doi: 10.1093/abbs/gmab083.
3
JQ1, a selective inhibitor of BRD4, suppresses retinoblastoma cell growth by inducing cell cycle arrest and apoptosis.
长链非编码 RNA LOXL1-AS1 通过调控 MAPK 信号通路促进视网膜母细胞瘤的增殖、侵袭,抑制凋亡。
Mol Cell Biochem. 2024 Apr;479(4):1011-1022. doi: 10.1007/s11010-023-04774-4. Epub 2023 Jun 5.
4
Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B.赖氨酸特异性去甲基化酶1(LSD1)的药理学抑制通过诱导生长停滞和DNA损伤诱导蛋白45β(GADD45B)来抑制肝细胞癌的生长。
MedComm (2020). 2023 May 24;4(3):e269. doi: 10.1002/mco2.269. eCollection 2023 Jun.
5
Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies.靶向性表观遗传学干预治疗癌症,重点关注儿科恶性肿瘤。
Biomolecules. 2022 Dec 28;13(1):61. doi: 10.3390/biom13010061.
JQ1,一种选择性的 BRD4 抑制剂,通过诱导细胞周期停滞和细胞凋亡来抑制视网膜母细胞瘤细胞的生长。
Exp Eye Res. 2021 Jan;202:108304. doi: 10.1016/j.exer.2020.108304. Epub 2020 Oct 17.
4
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia.Iadademstat(ORY-1001)的首次人体 I 期研究:一种首创的赖氨酸特异性组蛋白去甲基化酶 1A 抑制剂,用于治疗复发/难治性急性髓系白血病。
J Clin Oncol. 2020 Dec 20;38(36):4260-4273. doi: 10.1200/JCO.19.03250. Epub 2020 Oct 14.
5
EPZ015666, a selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an antitumour effect in retinoblastoma.EPZ015666,一种选择性蛋白精氨酸甲基转移酶 5(PRMT5)抑制剂,对视网膜母细胞瘤具有抗肿瘤作用。
Exp Eye Res. 2021 Jan;202:108286. doi: 10.1016/j.exer.2020.108286. Epub 2020 Oct 6.
6
LSD1 inhibition induces differentiation and cell death in Merkel cell carcinoma.赖氨酸特异性去甲基化酶1(LSD1)抑制可诱导默克尔细胞癌发生分化和细胞死亡。
EMBO Mol Med. 2020 Nov 6;12(11):e12525. doi: 10.15252/emmm.202012525. Epub 2020 Oct 7.
7
Natural products as LSD1 inhibitors for cancer therapy.用于癌症治疗的天然产物作为赖氨酸特异性去甲基化酶1(LSD1)抑制剂
Acta Pharm Sin B. 2020 Jun 20;11(3):621-31. doi: 10.1016/j.apsb.2020.06.007.
8
Functional genomics identifies new synergistic therapies for retinoblastoma.功能基因组学为视网膜母细胞瘤鉴定出新的协同治疗方法。
Oncogene. 2020 Jul;39(31):5338-5357. doi: 10.1038/s41388-020-1372-7. Epub 2020 Jun 22.
9
Crystal Structure of the LSD1/CoREST Histone Demethylase Bound to Its Nucleosome Substrate.与核小体底物结合的LSD1/CoREST组蛋白去甲基化酶的晶体结构。
Mol Cell. 2020 Jun 4;78(5):903-914.e4. doi: 10.1016/j.molcel.2020.04.019. Epub 2020 May 11.
10
Merkel cell polyomavirus activates LSD1-mediated blockade of non-canonical BAF to regulate transformation and tumorigenesis.默克尔细胞多瘤病毒激活 LSD1 介导的非典型 BAF 阻断以调节转化和肿瘤发生。
Nat Cell Biol. 2020 May;22(5):603-615. doi: 10.1038/s41556-020-0503-2. Epub 2020 Apr 13.